These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. Bing W; Knott A; Redwood C; Esposito G; Purcell I; Watkins H; Marston S J Mol Cell Cardiol; 2000 Aug; 32(8):1489-98. PubMed ID: 10900175 [TBL] [Abstract][Full Text] [Related]
30. Regulation of Ca(2+)-signaling in cardiac myofilaments. Solaro RJ Med Sci Sports Exerc; 1991 Oct; 23(10):1145-8. PubMed ID: 1758291 [TBL] [Abstract][Full Text] [Related]
31. Troponin and a Myopathy-Linked Mutation in Robaszkiewicz K; Wróbel J; Moraczewska J Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003645 [TBL] [Abstract][Full Text] [Related]
32. Zebrafish as a model for cardiac disease; Cryo-EM structure of native cardiac thin filaments from Danio Rerio. Bradshaw M; Squire JM; Morris E; Atkinson G; Richardson R; Lees J; Caputo M; Bigotti GM; Paul DM J Muscle Res Cell Motil; 2023 Sep; 44(3):179-192. PubMed ID: 37480427 [TBL] [Abstract][Full Text] [Related]
33. Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? Willott RH; Gomes AV; Chang AN; Parvatiyar MS; Pinto JR; Potter JD J Mol Cell Cardiol; 2010 May; 48(5):882-92. PubMed ID: 19914256 [TBL] [Abstract][Full Text] [Related]
34. Hypertrophic cardiomyopathy-causing Asp175asn and Glu180gly Tpm1 mutations shift tropomyosin strands further towards the open position during the ATPase cycle. Borovikov YS; Rysev NA; Karpicheva OE; Redwood CS Biochem Biophys Res Commun; 2011 Apr; 407(1):197-201. PubMed ID: 21376702 [TBL] [Abstract][Full Text] [Related]
35. In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene. Martins AS; Parvatiyar MS; Feng HZ; Bos JM; Gonzalez-Martinez D; Vukmirovic M; Turna RS; Sanchez-Gonzalez MA; Badger CD; Zorio DAR; Singh RK; Wang Y; Jin JP; Ackerman MJ; Pinto JR Circ Cardiovasc Genet; 2015 Oct; 8(5):653-664. PubMed ID: 26304555 [TBL] [Abstract][Full Text] [Related]
36. Modulation of thin filament activation by breakdown or isoform switching of thin filament proteins: physiological and pathological implications. Marston SB; Redwood CS Circ Res; 2003 Dec; 93(12):1170-8. PubMed ID: 14670832 [TBL] [Abstract][Full Text] [Related]
37. A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium. Bai F; Wang L; Kawai M J Muscle Res Cell Motil; 2013 Aug; 34(3-4):295-310. PubMed ID: 23700264 [TBL] [Abstract][Full Text] [Related]
38. A simple method for measuring the relative force exerted by myosin on actin filaments in the in vitro motility assay: evidence that tropomyosin and troponin increase force in single thin filaments. Bing W; Knott A; Marston SB Biochem J; 2000 Sep; 350 Pt 3(Pt 3):693-9. PubMed ID: 10970781 [TBL] [Abstract][Full Text] [Related]
39. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Bottinelli R; Coviello DA; Redwood CS; Pellegrino MA; Maron BJ; Spirito P; Watkins H; Reggiani C Circ Res; 1998 Jan 9-23; 82(1):106-15. PubMed ID: 9440709 [TBL] [Abstract][Full Text] [Related]
40. A cellular automaton model for the regulatory behavior of muscle thin filaments. Zou G; Phillips GN Biophys J; 1994 Jul; 67(1):11-28. PubMed ID: 7918978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]